Selected article for: "early life and RSV infection"

Author: Ahanchian, Hamid; Jones, Carmen M; Chen, Yueh-sheng; Sly, Peter D
Title: Respiratory viral infections in children with asthma: do they matter and can we prevent them?
  • Document date: 2012_9_13
  • ID: 0mnsm6s4_10
    Snippet: Much research interest has focused on the potential role respiratory viral infections play in the inception of asthma. It is well established that hospitalization for RSV bronchiolitis is a risk factor for asthma during childhood [37, 38] . Epidemiological studies have shown an increased risk of asthma with LRI caused by HRV. In the Childhood Origin of Asthma (COAST) birth cohort study, wheezing with RSV (odds ratio [OR], 2.6), HRV (OR, 9.8), or .....
    Document: Much research interest has focused on the potential role respiratory viral infections play in the inception of asthma. It is well established that hospitalization for RSV bronchiolitis is a risk factor for asthma during childhood [37, 38] . Epidemiological studies have shown an increased risk of asthma with LRI caused by HRV. In the Childhood Origin of Asthma (COAST) birth cohort study, wheezing with RSV (odds ratio [OR], 2.6), HRV (OR, 9.8), or both HRV and RSV (OR, 10) was associated with increased asthma risk at age six years [7] . The Childhood Asthma Study (CAS) in Perth, Australia showed that wheezing with HRV or RSV in the first year of life was a risk factor (OR, 2.5) for current wheeze at five years of age [4] . Infant birth about four months before the winter virus peak carried the highest risk of developing asthma compared with birth 12 months before the peak [39] . The risk of asthma is increased by severe LRI (sLRI), especially in the presence of allergic sensitization in early life [4, 25] . There appears to be a synergistic interaction between viral infection and allergic sensitization, suggesting a "two hit" model for induction of persistent asthma. These data also provide a series of novel strategies for the primary prevention of asthma by prevention of either allergic sensitization or of sLRI in high risk children. This strategy is also supported in a study by Simoes et al. [40] , in which the use of palivizumab to prevent RSV infection decreased the risk of recurrent wheezing in nonatopic premature infants.

    Search related documents:
    Co phrase search for related documents
    • age asthma risk and asthma inception: 1
    • age asthma risk and asthma risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • age asthma risk and asthma risk factor: 1, 2, 3, 4, 5
    • age asthma risk and birth cohort: 1, 2, 3, 4, 5, 6, 7
    • age asthma risk and birth cohort study: 1, 2, 3
    • age asthma risk and early life: 1, 2, 3, 4, 5, 6
    • age year and allergic sensitization: 1
    • age year and asthma primary prevention: 1
    • age year and asthma risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • age year and asthma risk factor: 1
    • age year and birth cohort: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • age year and birth cohort study: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • age year and birth compare: 1
    • age year and current wheeze: 1
    • age year and develop asthma: 1, 2
    • age year and early life: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • allergic sensitization and asthma risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • allergic sensitization and asthma risk factor: 1, 2, 3, 4
    • allergic sensitization and birth cohort: 1, 2, 3, 4, 5